Officer James Hamilton Files to Sell $750K in ARWR Stock Near 52-Week High
Summary
Officer James Hamilton has filed a Form 144 indicating intent to sell 10,000 shares of Arrowhead Pharmaceuticals stock, valued at approximately $750,000, continuing a pattern of insider sales while the stock trades near its 52-week high.
Key Events
-
Officer Files Intent to Sell Shares
James Hamilton, an officer of Arrowhead Pharmaceuticals, Inc., filed a Form 144 indicating intent to sell 10,000 common shares.
-
Significant Dollar Value Proposed
The proposed sale has an approximate market value of $749,997.60.
-
Follows Prior Insider Sale
This filing comes after a previous sale of 10,000 shares by the same officer on March 5, 2026, for $641,870.05, indicating a pattern of insider distribution.
-
Stock Trading Near 52-Week High
The proposed sale occurs while ARWR stock is trading near its 52-week high, potentially indicating profit-taking by the insider.
Analysis
This Form 144 filing signals an officer's intent to sell a significant amount of company stock, approximately $750,000 worth. This follows a previous sale by the same officer in March, indicating a pattern of insider distribution. While the amount represents a small fraction of the company's large market capitalization, the timing of the sale near the stock's 52-week high suggests the officer may be locking in gains. This insider selling occurs despite the company's recent strong financial performance and return to profitability reported in Q1 FY2026, which could be interpreted by investors as a signal of reduced conviction.
At the time of this filing, ARWR was trading at $74.40 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $10.4B. The 52-week trading range was $12.44 to $76.76. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.